178 related articles for article (PubMed ID: 17242979)
1. YKL-40 protein expression in normal adult human tissues--an immunohistochemical study.
Ringsholt M; Høgdall EV; Johansen JS; Price PA; Christensen LH
J Mol Histol; 2007 Mar; 38(1):33-43. PubMed ID: 17242979
[TBL] [Abstract][Full Text] [Related]
2. YKL-40 expression in benign and malignant lesions of the breast: a methodologic study.
Roslind A; Johansen JS; Junker N; Nielsen DL; Dzaferi H; Price PA; Balslev E
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):371-81. PubMed ID: 18091378
[TBL] [Abstract][Full Text] [Related]
3. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils.
Volck B; Price PA; Johansen JS; Sørensen O; Benfield TL; Nielsen HJ; Calafat J; Borregaard N
Proc Assoc Am Physicians; 1998; 110(4):351-60. PubMed ID: 9686683
[TBL] [Abstract][Full Text] [Related]
4. Regulation of YKL-40 production by human articular chondrocytes.
Johansen JS; Olee T; Price PA; Hashimoto S; Ochs RL; Lotz M
Arthritis Rheum; 2001 Apr; 44(4):826-37. PubMed ID: 11315922
[TBL] [Abstract][Full Text] [Related]
5. YKL-40 protein expression in the early developing human musculoskeletal system.
Johansen JS; Høyer PE; Larsen LA; Price PA; Møllgård K
J Histochem Cytochem; 2007 Dec; 55(12):1213-28. PubMed ID: 17712177
[TBL] [Abstract][Full Text] [Related]
6. YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation.
Roslind A; Johansen JS
Methods Mol Biol; 2009; 511():159-84. PubMed ID: 19347297
[TBL] [Abstract][Full Text] [Related]
7. The distribution of YKL-40 in osteoarthritic and normal human articular cartilage.
Volck B; Ostergaard K; Johansen JS; Garbarsch C; Price PA
Scand J Rheumatol; 1999; 28(3):171-9. PubMed ID: 10380840
[TBL] [Abstract][Full Text] [Related]
8. YKL-40 in giant cells and macrophages from patients with giant cell arteritis.
Johansen JS; Baslund B; Garbarsch C; Hansen M; Stoltenberg M; Lorenzen I; Price PA
Arthritis Rheum; 1999 Dec; 42(12):2624-30. PubMed ID: 10616010
[TBL] [Abstract][Full Text] [Related]
9. Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity?
Johansen JS; Milman N; Hansen M; Garbarsch C; Price PA; Graudal N
Respir Med; 2005 Apr; 99(4):396-402. PubMed ID: 15763444
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of YKL-40 protein in epithelial ovarian cancer tissues.
Yang GF; Cai PY; Li XM; Deng HX; He WP; Xie D
Ai Zheng; 2009 Feb; 28(2):142-5. PubMed ID: 19550125
[TBL] [Abstract][Full Text] [Related]
11. YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.
Roslind A; Knoop AS; Jensen MB; Johansen JS; Nielsen DL; Price PA; Balslev E
Breast Cancer Res Treat; 2008 Nov; 112(2):275-85. PubMed ID: 18157633
[TBL] [Abstract][Full Text] [Related]
12. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer.
Junker N; Johansen JS; Andersen CB; Kristjansen PE
Lung Cancer; 2005 May; 48(2):223-31. PubMed ID: 15829322
[TBL] [Abstract][Full Text] [Related]
13. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells.
Junker N; Johansen JS; Hansen LT; Lund EL; Kristjansen PE
Cancer Sci; 2005 Mar; 96(3):183-90. PubMed ID: 15771622
[TBL] [Abstract][Full Text] [Related]
14. Subcellular localization of YKL-40 in normal and malignant epithelial cells of the breast.
Roslind A; Balslev E; Kruse H; Staergaard B; Horn T
Ultrastruct Pathol; 2008; 32(3):101-6. PubMed ID: 18570155
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis.
Furuhashi K; Suda T; Nakamura Y; Inui N; Hashimoto D; Miwa S; Hayakawa H; Kusagaya H; Nakano Y; Nakamura H; Chida K
Respir Med; 2010 Aug; 104(8):1204-10. PubMed ID: 20347285
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
[TBL] [Abstract][Full Text] [Related]
17. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.
Kucur M; Isman FK; Balci C; Onal B; Hacibekiroglu M; Ozkan F; Ozkan A
Urol Oncol; 2008; 26(1):47-52. PubMed ID: 18190830
[TBL] [Abstract][Full Text] [Related]
18. Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells.
Mylin AK; Rasmussen T; Johansen JS; Knudsen LM; Nørgaard PH; Lenhoff S; Dahl IM; Johnsen HE;
Eur J Haematol; 2006 Nov; 77(5):416-24. PubMed ID: 16930142
[TBL] [Abstract][Full Text] [Related]
19. Association between YKL-40 and adult primary astrocytoma.
Zhang W; Kawanishi M; Miyake K; Kagawa M; Kawai N; Murao K; Nishiyama A; Fei Z; Zhang X; Tamiya T
Cancer; 2010 Jun; 116(11):2688-97. PubMed ID: 20499402
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure.
Bilim O; Takeishi Y; Kitahara T; Ishino M; Sasaki T; Suzuki S; Shishido T; Kubota I
J Card Fail; 2010 Nov; 16(11):873-9. PubMed ID: 21055651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
